Literature DB >> 9020877

P52PAI-1 gene expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells: mechanism of induction and involvement in the morphological response.

P J Higgins1, M P Ryan, D M Jelley.   

Abstract

Sodium n-butyrate-induced flat reversion in v-K-ras oncogene-transformed rat kidney (KNRK) cells is associated with transcriptional activation of the p52PAI-1 gene (which encodes the type-1 inhibitor of plasminogen activator). Butyrate-initiated expression of p52PAI-1 mRNA and protein correlated with induced cell spreading and preceded development of cell-to-substrate focal adhesions. Such undersurface matrix contact structures, which are absent from parental KNRK cells, require proximal PAI-1 deposition for their stabilization. Stimulated p52PAI-1 expression by flat revertants (approximating 25-fold that of control cells) and the accompanying cytoarchitectural reorganization appeared to be programmed responses to butyrate as both events required de novo RNA and protein synthesis, metabolic characteristics consistent with a secondary pathway of gene regulation. To assess the relevance of p52PAI-1 induction to the process of flat reversion more critically, a molecular genetic approach was designed to maintain high-level constitutive p52PAI-1 synthesis in the absence of butyrate. KNRK cells transfected with a Rc/CMVPAI plasmid construct, in which expression of a p52PAI-1 cDNA insert was driven by enhancer-promoter sequences from the immediate-early gene of human cytomegalovirus, formed colonies comprised of flat-revertant-like cells with a greater frequency than did cells transfected with the Rc/CMV vector alone (24.8% and 1.7% respectively). Comparative analysis of randomly selected Rc/ CMVPAI clones indicated that a 10-fold increase in immunoreactive p52PAI-1 protein, relative to Rc/CMV isolates, correlated with generation of the flat phenotype. These data suggest that induced p52PAI-1 expression probably functions in the development of morphological revertants in the KNRK cell system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020877      PMCID: PMC1218087          DOI: 10.1042/bj3210431

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

Review 1.  Directed plasminogen activation at the surface of normal and malignant cells.

Authors:  J Pöllänen; R W Stephens; A Vaheri
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

2.  Identification of the 52 kDa cytoskeletal-like protein of cytochalasin D-stimulated normal rat kidney (NRK/CD) cells as substrate-associated glycoprotein p52 [plasminogen-activator inhibitor type-1 (PAI-1)]. Expression of p52 (PAI-1) in NRK/CD cells is regulated at the level of mRNA abundance.

Authors:  P J Higgins; M P Ryan
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  Isolation of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.

Authors:  H Yamada; T Omata-Yamada; N Wakabayashi-Ito; S G Carter; P Lengyel
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Growth state-regulated expression of p52(PAI-1) in normal rat kidney cells.

Authors:  M P Ryan; P J Higgins
Journal:  J Cell Physiol       Date:  1993-05       Impact factor: 6.384

Review 5.  Control of p52(PAI-1) gene expression in normal and transformed rat kidney cells: relationship between p52(PAI-1) induction and actin cytoarchitecture.

Authors:  M P Ryan; P J Higgins
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

6.  p52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells.

Authors:  P J Higgins; M P Ryan
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

7.  Induced expression of p52(PAI-1) in normal rat kidney cells by the microfilament-disrupting agent cytochalasin D.

Authors:  P J Higgins; M P Ryan; K M Providence
Journal:  J Cell Physiol       Date:  1994-04       Impact factor: 6.384

8.  Cell-shape regulation and matrix protein p52 content in phenotypic variants of ras-transformed rat kidney fibroblasts. Functional analysis and biochemical comparison of p52 with proteins implicated in cell-shape determination.

Authors:  P J Higgins; P Chaudhari; M P Ryan
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

9.  Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.

Authors:  G J Ciambrone; P J McKeown-Longo
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

10.  Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts.

Authors:  J Pöllänen; K Hedman; L S Nielsen; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1988-01       Impact factor: 10.539

View more
  4 in total

1.  Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.

Authors:  Katherine B Schuetze; Matthew S Stratton; Weston W Blakeslee; Michael F Wempe; Florence F Wagner; Edward B Holson; Yin-Ming Kuo; Andrew J Andrews; Tonya M Gilbert; Jacob M Hooker; Timothy A McKinsey
Journal:  J Pharmacol Exp Ther       Date:  2017-02-07       Impact factor: 4.030

2.  TGF-β1-Induced Expression of the Anti-Apoptotic PAI-1 Protein Requires EGFR Signaling.

Authors:  Stephen P Higgins; Rohan Samarakoon; Craig E Higgins; Jennifer Freytag; Cynthia E Wilkins-Port; Paul J Higgins
Journal:  Cell Commun Insights       Date:  2009

3.  SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair.

Authors:  Kirwin M Providence; Stephen P Higgins; Andrew Mullen; Ashley Battista; Rohan Samarakoon; Craig E Higgins; Cynthia E Wilkins-Port; Paul J Higgins
Journal:  Arch Dermatol Res       Date:  2008-04-02       Impact factor: 3.017

4.  PAI-1 Expression Is Required for HDACi-Induced Proliferative Arrest in ras-Transformed Renal Epithelial Cells.

Authors:  Stephen P Higgins; Craig E Higgins; Paul J Higgins
Journal:  Int J Cell Biol       Date:  2011-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.